manual on management of drugs

More documents

Recommendations

Info

ABBREVIATIONS AD CP CDD CDDA D(F) DC DCP DDG DDS DHC DHO DP DRMP DTCO D/PHVS DD DDG (LS) DESC DGHS DHS DRA FR GMP HSCO ID IDD MCH MOH MSD MT & S NDQAL NORAD OIC ORS OT ODD : Assistant Director : Chief pharmacist : Cosmetics, Devices and Drugs : Cosmetics, Devices and Drugs Authority : Director (Finance) : Dental Clinic : Director Campaign : Deputy Director General : Divisional Drug Store : Divisional Health Center : Divisional Health Officer : Divisional Pharmacist : Divisional Registered Medical Practitioner : District Tuberculosis Control Officer : Director/ Public Health Veterinary Service : Deputy Director : Deputy Director General (Laboratory Services) : Drug Evaluation Sub Committee : Director General of Health Services : Department of Health Services : Drug Regulatory Authority : Financial Regulations : Good Manufacturing Practices : Head Stock Control Officer : Infectious Diseases : In-Door Dispensary : Maternal and Child Health : Medical Officer of Health : Medical Supplies Division : Medical Technology & Supplies : National Drug Quality Assurance Laboratory : Norwegian Agency for Development Co-operation : Officer in charge : Oral Rehydration Salts : Operating Theater : Out-Door Dispensary ix
OPD PDHS PPA RDHS RMSD SDHC SMO STV SV SH SK SLSI SPC TAC TB WHO : Out Patient Department : Provincial Director of Health Services : Programme planning Assistant : Regional Director of Health Services : Regional Medical Supplies Divisions : Sub Divisional Health Services : Senior Medical Officer : Stock Transfer Voucher : Stock Verification : Secretary Health : Store Keeper : Sri Lanka Standards Institute : State Pharmaceuticals Corporation : Technical Advisory Committee : Tuberculosis : World Health Organization x
Page 2 and 3: MANUAL ON MANAGEMENT OF DRUGS SECON
Page 4 and 5: MESSAGE BY THE SECRETARY/ MINISTRY
Page 6 and 7: ACKNOWLEDGEMENT It is a great pleas
Page 8 and 9: Dr. J. M. J. Munasinghe Dr. K. C. L
Page 12 and 13: CONTENTS Message by the Hon. Minist
Page 14 and 15: X Form for Drug sample for quality
Page 16 and 17: CHAPTER 1 INTRODUCTION 1.Ensuring a
Page 18 and 19: 3.The expenditure on drugs has been
Page 20 and 21: of poisons, opium, and dangerous dr
Page 22 and 23: (Medical Technology & Supplies) No
Page 24 and 25: c) NDQAL for quality assurance of d
Page 26 and 27: Deputy Director General (Finance) D
Page 28 and 29: (d) The Institutional Drug Therapeu
Page 30 and 31: CHAPTER 4 ESTIMATION OF ANNUAL REQU
Page 32 and 33: Step 2 Identify the stock available
Page 34 and 35: In the case of institutions under t
Page 36 and 37: oard appointed by him and a report
Page 38 and 39: Head of the Institution may add any
Page 40 and 41: ii. Injections costing Rs. 25.00 or
Page 42 and 43: 42. Delivery schedules are planned
Page 44 and 45: CHAPTER 6 CARE IN PRESCRIBING DRUGS
Page 46 and 47: CHAPTER 7 DISTRIBUTION AND LOGISTIC
Page 48 and 49: the institution. Records of the inv
Page 50 and 51: RMSD or institutional stores, the o
Page 52 and 53: CHAPTER 8 QUALITY ASSURANCE OF DRUG
Page 54 and 55: ioavailability. Further, in apprais
Page 56 and 57: x. Details of any preservative adde
Page 58 and 59: To request institutions to inform t
Page 60 and 61:
CHAPTER 9 STORAGE OF DRUGS. 1. Prop
Page 62 and 63:
xi. Storage of vaccine in the refri
Page 64 and 65:
CHAPTER 10 MONITORING OF CONSUMPTIO
Page 66 and 67:
ii. VEN analysis ( See annexure XV
Page 68 and 69:
9. Monitoring of quality of drugs;
Page 70 and 71:
alance as per ledger, actual balanc
Page 72 and 73:
1.3 In case of institutions coming
Page 74 and 75:
Ampoules should be crushed and buri
Page 76 and 77:
ANNEXURE I1: Main functions of Medi
Page 78 and 79:
I - Annual stock holding cost as a
Page 80 and 81:
Anti Rabies cell culture vaccine. (
Page 82 and 83:
unobservable (animal dead, killed,
Page 84 and 85:
on D0, D3, D7, D14 & D30. 6.1.2 For
Page 86 and 87:
All patients who receive rabies PET
Page 88 and 89:
Monthly return for vaccine consumpt
Page 90 and 91:
Death in the house / outside a Medi
Page 92 and 93:
2.2 In case of major exposures: 2.2
Page 94 and 95:
ANNEXURE - V MyNo……/…../….
Page 96 and 97:
Advertisement Screening Unit Unit o
Page 98 and 99:
ANNEXURE VIII (To be amended To: My
Page 100 and 101:
ANNEXURE X ……………………
Page 102 and 103:
6. Quality failure of registration
Page 105 and 106:
ANNEXURE XIII Lot Card SR No……
Page 107 and 108:
ANNEXURE XV VEN Analysis This analy
Page 109:
Sample Guidelines for VEN Category
Page 112 and 113:
Unsatisfactory clinical response, a
Page 114 and 115:
Local Agents of supplier (on reques
show all

manual on management of drugs

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?